SchizophreniaBy Lesha M. Delaney

LeTourneau University

PSYC 5013

Sch

izophre

nia

D

isord

er

295.9

Potential Causation Factors

interaction of biological (brain

abnormalities, predisposition),

environmental stressors.

Negative & Positive

Symptoms may be contingent

upon one another through

combined Upstream Pathological

Ailment progression.

Sch

izophre

nia

D

isord

er

Fact

s • Exact Causes Unknown

• Multifaceted• Effected by Epigenetic

Mechanisms

Psyc

hodyn

am

ic

Pers

pect

ive

•Oldest view, holding

largely that parents may

be to blame. Support

lacking.•Sigmund Freud- Digress

to previous phases such as

the narcissistic pre-ego

period.•Frieda Fromm-Reichmann- Coined the

term, Schizophrenic Mothers.

Behavi

ora

l Pe

rspect

ive

•Inadequate intimate

and social relationships.

•Reinforcements based

on rewards from bizarre

attention.•Can be eliminated with

appropriate reinforcements (although research does

not support this).

Cognit

ive

Pers

pect

ive

•Agree that sufferers

truly experience hearing

voices and seeing hallucinations.•Sufferers take a

coherent track to insanity.•Believe that schizophrenia is a result

of faulty sensory, which

leads them toward the

disorder.

Soci

ocu

ltura

l Pe

rspect

ive

•Genetic Contributions•Social Labeling; Self-

fulfilling prophecy•Double Bind Hypothesis

Bio

logic

al

Pers

pect

ive

PredispositionBrain AbnormalitiesFetus Environment and

Viral likelihood.

Key

Dia

gnost

ic

Cri

teri

a D

MS-V •Schizophrenia 295.90

•Diagnostic Criteria to

include A-F in DSM-V.

Dia

gnost

ic

Featu

res

•Impaired functioning:

Significant social and or

occupational functioning.•Symptoms: cognitive,

behavioral, emotional

dysfunctions, with none

as pathognomonic.

Concl

usi

on

Although the main causes of schizophrenia

are not precisely known at present, mental health

professionals are certain that the disorder is

multifaceted. The most likely causes appear to include

a combination of both genetics and environments.

Research backs a culmination of drug therapy to

include atypical antipsychotics and cognitive-

behavioral therapy in the treatment of schizophrenia,

of which are used most widely.

Refe

rence

s:

Comer, R.J. (2012). Abnormal psychology (8th

ed.). New York, NY: Worth.

Javitt, D. C. (2014). Reports. Balancing

Therapeutic Safety and Efficacy to Improve

Clinical and Economic Outcomes in

Schizophrenia: A Clinical Overview. American

Journal of Managed Care, 20(8), S160-S165.

Lei, C., Johnston, J. A., Kinon, B. J., Stauffer, V.,

Succop, P., Marques, T. R., & Ascher-Svanum,

H. (2013). The longitudinal interplay between

negative and positive symptom trajectories in

patients under antipsychotic treatment: a post

hoc analysis of data from a randomized, 1-year

pragmatic trial. BMC Psychiatry, 13(1), 1-19.

doi:10.1186/1471-244X-13-320.

Ouzir, M., Azorin, J., Adida, M., Boussaoud, D.,

& Battas, O. (2012). Insight in schizophrenia:

From conceptualization to neuroscience.

Psychiatry & Clinical Neurosciences, 66(3),

167-179. doi:10.1111/j.1440-

1819.2012.02325.x.